DALLAS, Sept. 30, 2015 /PRNewswire/ -- Swiss Avenue SurgiCenter, LP /Select Pain Health Services, LLC is pleased to announce the first commercial implantation of the Senza® spinal cord stimulator (SCS) in Dallas, Texas. The Senza SCS system, which delivers Nevro's proprietary HF10™ therapy (Nevro Corporation, Menlo Park, CA), is a recently FDA-approved spinal cord stimulator that has demonstrated superior results compared to traditional SCS for the treatment of back and leg pain in a large multicenter study in the United States.
"I'm honored to be the first pain physician in Dallas to offer this promising technology to patients with chronic low back and leg pain," said Dr. Tibor Racz. "The results of the SENZA-RCT have shown that this therapy offers more pain relief than traditional therapy while treating more patients, and I'm confident we will able to provide similar outcomes as we incorporate HF10 therapy into our practice."
100 million people in the U.S. suffer from common chronic pain conditions, and chronic pain is the primary cause of adult disability in the United States. The majority of these pain conditions are felt in the back or legs. There are a variety of treatment options for chronic pain that range from medications to surgical interventions.
Spinal cord stimulation (SCS) represents another option to treat chronic pain. It involves the delivery of electrical signals to the spinal cord in order to alter pain signals to the brain. The electrical pulses are delivered by small electrodes on leads that are placed near the spinal cord and are connected to a compact, battery-powered generator implanted under the skin. SCS is a reversible therapy that has helped hundreds of thousands of people experience relief from chronic pain.
HF10 therapy, Nevro's high-frequency therapy at 10,000 Hz, represents a significant advance in spinal cord stimulation. FDA approval for HF10 therapy included superiority labeling over traditional SCS therapy (HF10 therapy is the only SCS therapy with this distinction), validating that HF10 therapy reduces pain more effectively in more patients.
Additionally, HF10 therapy is also the only SCS therapy indicated to deliver pain relief without paresthesia (a stimulation-induced sensation, such as tingling, burning, or pricking, which is the basis of traditional SCS) and is also the only SCS system approved by FDA to be used without patient restrictions on driving while receiving therapy.
About Swiss Avenue SurgiCenter, LP
Swiss Avenue SurgiCenter is an ambulatory surgery center providing same-day procedures in Dallas, Texas. Swiss is operated by Select Pain Health Services, LLC.
Please visit www.selectpain.com for more information.
About Tibor Racz, MD
Dr. Tibor Racz finished his residency in anesthesiology at The University of Texas Southwestern Medical Center in Dallas. He then went on to complete a fellowship in pain management at Texas Tech University Health Sciences Center. There he learned under the tutelage of his father, Dr. Gabor Racz, who is an internationally recognized specialist in the sub-specialty of pain management. Dr. Racz has a special interest in neuromodulation for pain and intrathecal pump therapy for both pain and spasticity. He is board certified in both anesthesiology and pain medicine. For more information on Dr. Racz, please visit www.pinnaclepainmed.com/Physicians/Physician-Biography/Tibor-Racz.aspx.
SOURCE Select Pain Health Services, LLC